Inhibition of the Epidermal Growth Factor Receptor Family of Tyrosine Kinases as an Approach to Cancer Chemotherapy: Progression from Reversible to Irreversible Inhibitors

This publication has 89 references indexed in Scilit:

• ErbB kinases and NDF signaling in human prostate cancer cells
  Oncogene, 1997
• Effects of Sulfhydryl Modification Reagents on the Kinase Activity of the Epidermal Growth Factor Receptor
  Biochemistry, 1997
• ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
  The EMBO Journal, 1997
• Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation
  Oncogene, 1997
• 5‘-(p-Fluorosulfonylbenzoyl)-2‘(or 3‘)-(methylanthraniloyl)adenosine, Fluorescent Affinity Labels for Adenine Nucleotide Binding Sites: Interaction with the Kinase Active Site of the Receptor for Epidermal Growth Factor
  Biochemistry, 1996
• Catalytic specificity of protein-tyrosine kinases is critical for selective signalling
  Nature, 1995
• A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
  Science, 1994
• Signalling pathways as target for anticancer drug development
  Pharmacology & Therapeutics, 1994
• SH2 and SH3 domains
  Current Biology, 1993
• Intermolecular association of the p185 protein and EGF receptor modulates EGF receptor function
  Cell, 1990